يعرض 1 - 10 نتائج من 17 نتيجة بحث عن '"mucosa inflammation"', وقت الاستعلام: 0.92s تنقيح النتائج
  1. 1
  2. 2

    المساهمون: Pavlidis, Nicholas [0000-0002-2195-9961], Aravantinos, Gerasimos [0000-0002-2106-1713], Kalofonos, H. P. [0000-0002-3286-778X]

    المصدر: Annals of Oncology

    مصطلحات موضوعية: medicine.medical_treatment, Docetaxel, Skin disease, Gastroenterology, Carboplatin, Granulocyte colony-stimulating factor, Antineoplastic agents, Antineoplastic Combined Chemotherapy Protocols, Granulocyte Colony-Stimulating Factor, Prospective Studies, Treatment outcome, Drug safety, Etoposide, Ovarian Neoplasms, Multicenter study, Clinical trial, Oxaliplatin, Local, Oncology, Vertigo, Disease Progression, Taxoids, Infection, Human, Diarrhea, Neoplasm recurrence, medicine.medical_specialty, Bone marrow suppression, Paclitaxel, Clinical article, Febrile neutropenia, Antineoplastic Agents, Methylprednisolone, Article, Disease-Free Survival, Ovarian cancer, Humans, Platinum-resistant, Cancer recurrence, Aged, Disease progression, Drug infusion, Recombinant granulocyte colony stimulating factor, Follow up, Myalgia, Leukopenia, Monotherapy, medicine.disease, Cancer combination chemotherapy, Drug effect, Regimen, Drug resistance, Cisplatin, Ovarian neoplasms, Controlled clinical trial, Nausea and vomiting, Phytogenic, Middle aged, Fatigue, Priority journal, Platinum derivative, Anemia, Vinorelbine, Hematology, Middle Aged, Arthralgia, Ondansetron, Anorexia, Treatment Outcome, Drug choice, Female, medicine.symptom, medicine.drug, Adult, Abdominal pain, Neutropenia, Ovary cancer, Disease-free survival, Navelbine, Vinblastine, Mucosa inflammation, Antineoplastic combined chemotherapy protocols, Internal medicine, Neurotoxicity, medicine, Chemotherapy, Phase 2 clinical trial, Stomatitis, business.industry, Alopecia, Taxane derivative, Gemcitabine, Thrombocytopenia, Antineoplastic Agents, Phytogenic, Cancer survival, Surgery, Drug efficacy, Doxorubicin, Drug Resistance, Neoplasm, Neoplasm, Neoplasm Recurrence, Local, Antiemetic agent, Topotecan, business, Controlled study, Constipation, Prospective studies

  3. 3
    دورية أكاديمية
  4. 4
    دورية أكاديمية
  5. 5

    المؤلفون: O'Neil, Bert H.

    المساهمون: Uludağ Üniversitesi/Tıp Fakültesi/Tıbbi Onkoloji Anabilim Dalı., Kanat, Özkan

    مصطلحات موضوعية: Continuous infusion, Drug targeting, Survival rate, Cetuximab, Gimeracil plus oteracil potassium plus tegafur, Docetaxel, Review, Medical decision making, Treatment response, Metastasis, Gastroesophageal junction adenocarcinoma, Multiple cycle treatment, Randomized controlled trial (topic), Targeted treatment, Pathology, Drug fatality, Overall survival, Treatment outcome, Etoposide, Priority journal, Survival time, Drug tolerability, Panitumumab, Folinic acid, Anemia, Nausea, Immunohistochemistry, Esophagus cancer, Chemotherapy-naive patients, Bevacizumab, Oxaliplatin, Europe, Clinical trial (topic), Oncology, Antineoplastic agent, Decreased appetite, Molecularly targeted therapy, Drug dose reduction, Fluorouracil, Human, Diarrhea, Drug megadose, Quality of life, Asia, Neutropenia, Plus cisplatin, Stomach cancer, Febrile neutropenia, Drug delivery system, Antiangiogenic therapy, Hypokalemia, Cancer mortality, Cause of death, Stomach tumor, Irinotecan, Epidermal growth factor receptor 2, Targeted therapies, Stomach perforation, Mucosa inflammation, 1st-line treatment, Rash, Thromboembolism, Chemotherapy, Everolimus, Gene mutation, Phase 3 clinical trial (topic), Ramucirumab, Rivoceranib, Line, Capecitabine, Placebo, Epirubicin, Cancer prognosis, Stomatitis, Vasculotropin, Oncogene K ras, Vasculotropin receptor 1, Phase-II trial, Trastuzumab, Vasculotropin receptor 2, Monotherapy, Metastatic stomach cancer, Multicenter study (topic), Cancer survival, Cancer combination chemotherapy, Methotrexate, Clinical effectiveness, Acne, Doxorubicin, Progression free survival, Protein expression, Cisplatin, Gastric cancer, Prognostic model, Phase 2 clinical trial (topic), Phosphatidylinositol 3 kinase

  6. 6

    المساهمون: Uludağ Üniversitesi/Tıp Fakültesi/Onkoloji Anabilim Dalı., Uludağ Üniversitesi/Veterinerlik Fakültesi/Radyasyon Onkolojisi Anabilim Dalı., Kurt, Ender, Çubukçu, Erdem, Ölmez, Ömer Fatih, Kurt, Meral, Avcı, Nilüfer, Evrensel, Türkkan, Manavoǧlu, Osman, AAJ-1027-2021, AAA-3961-2020

  7. 7
    دورية أكاديمية
  8. 8
    مراجعة
  9. 9

    المساهمون: Pavlidis, Nicholas [0000-0002-2195-9961]

    المصدر: European journal of haematology

    مصطلحات موضوعية: Oncology, Male, Cancer relapse, Mitoguazone, Lymphoma, B-cell, Cancer regression, Lymphoma, B-Cell/drug therapy, Deoxycytidine, Cancer growth, Controlled clinical trial, Large cell lymphoma, Antineoplastic Combined Chemotherapy Protocols, 80 and over, Refractory Diffuse Large B-Cell Lymphoma, Treatment outcome, Relapse, Deoxycytidine/administration & dosage/*analogs & derivatives, Etoposide, Priority journal, Aged, 80 and over, Remission Induction, Cytarabine, Anemia, Nausea, Vinorelbine, Combination chemotherapy, Hematology, General Medicine, Middle Aged, Diffuse, Multicenter study, Clinical trial, Vincristine, Granulocyte colony stimulating factor, Vinblastine/administration & dosage/*analogs & derivatives, Female, Lymphoma, Large B-Cell, Diffuse/*drug therapy, Lymphoma, Large B-Cell, Diffuse, Large-cell, Human, medicine.drug, Adult, medicine.medical_specialty, Neutropenia, Lymphoma, B-Cell, Bone marrow suppression, Fever, Vomiting, Clinical article, Febrile neutropenia, Navelbine, Salvage therapy, Side effect, Vinblastine, Methylprednisolone, Article, Refractory, Mucosa inflammation, Median follow-up, Antineoplastic combined chemotherapy protocols, Internal medicine, Neurotoxicity, medicine, Humans, Salvage Therapy/*methods, Ifosfamide, Phase 2 clinical trial, Cyclophosphamide, Chemosensitivity, Survival analysis, Epirubicin, Aged, Salvage Therapy, Stomatitis, business.industry, Alopecia, Follow up, Leukopenia, Thrombocytopenia, Gemcitabine, Survival Analysis, Cancer survival, Cancer combination chemotherapy, B cell lymphoma, Antineoplastic Combined Chemotherapy Protocols/*administration & dosage/toxicity, Drug efficacy, Regimen, Prednisone, Cisplatin, business, Controlled study

  10. 10